Skip to main content

Fried Frank M&A/PE Quarterly Newsletter, Winter 2021

Alerts and newsletters | December 9, 2021

  • Where Things Stand at the End of 2021
  • Questions About Poison Pills After the Delaware Supreme Court Upholds the Invalidity of the Williams Pill
  • New SEC Guidance, Reversing Precedent, Will Limit Companies' Ability To Exclude Environmental and Other Social Policy-Related Shareholder Proposals
  • Chancery Decision Underscores Risks to Dissident Stockholders of Not Submitting Advance Notice Director Nominations Well in Advance of the Deadline—Rosenbaum v. CytoDyn
  • Other Decisions and Developments of Interest This Quarter
  • M&A/PE Round-Up

Additional information

icon View File

This communication is for general information only. It is not intended, nor should it be relied upon, as legal advice. In some jurisdictions, this may be considered attorney advertising. Please refer to the firm’s data policy page for further information.